Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.
- 1 April 2003
- journal article
- clinical trial
- Published by Wiley in Helicobacter
- Vol. 8 (2), 111-119
- https://doi.org/10.1046/j.1523-5378.2003.00131.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus ReportAlimentary Pharmacology & Therapeutics, 2002
- A Multicenter, Double‐Blind Study on Triple Therapy with Lansoprazole, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori in Japanese Peptic Ulcer PatientsHelicobacter, 2001
- The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pyloriEuropean Journal of Gastroenterology & Hepatology, 2001
- Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori—a randomized, controlled trialAlimentary Pharmacology & Therapeutics, 1999
- Eradication of Helicobacter pylori by a 1-week course of famotidine, amoxicillin and clarithromycinEuropean Journal of Gastroenterology & Hepatology, 1998
- Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A reviewGastroenterology, 1996
- Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrenceAlimentary Pharmacology & Therapeutics, 1994
- Effect of Triple Therapy (Antibiotics plus Bismuth) on Duodenal Ulcer HealingAnnals of Internal Medicine, 1991
- Helicobacter pylori and the Pathogenesis of Gastroduodenal InflammationThe Journal of Infectious Diseases, 1990
- Campylobacter pylori and Peptic Ulcer DiseaseGastroenterology, 1989